Tus kws kho mob
QP68-20 MHCP Pharmacy Benefit Update - Eylea®, Iluvien®, Lucentis®, Ozurdex® ,Retisert™ and Yutiq®
Hnub Tim pib siv tau lub khoos kas: Lub Xya Hli Ntuj Tim 22, 2020
Tshawb Nrhiav
Nthuav pom cov txiaj ntsig tshwm sim 1961 - 1970 ntawm 4269
Tus kws kho mob
QP62-20 Medicaid Sleep Management – Home Sleep Studies
Hnub Tim pib siv tau lub khoos kas: Lub Xya Hli Ntuj Tim 22, 2020
Tus kws kho mob
QP67-20 Commercial Pharmacy Benefit Exclusion for DurystaTM, Iluvien®, Retisert® and Yutiq®
Hnub Tim pib siv tau lub khoos kas: Lub Xya Hli Ntuj Tim 22, 2020
Tus kws kho mob
QP63-20 MDH Guidance to Support Hospital Patients with Disabilities and Pediatric Patients
Hnub Tim pib siv tau lub khoos kas: Lub Xya Hli Ntuj Tim 22, 2020
Tus kws kho mob
QP69-20 Commercial Pharmacy Benefit Update – New Drug-Related Prior Authorization (PA) Criteria: Risdiplam
Hnub Tim pib siv tau lub khoos kas: Lub Xya Hli Ntuj Tim 22, 2020
Tus kws kho mob
QP65-20 Commercial Pharmacy Benefit Update – New Drug-Related Prior Authorization (PA) Criteria: Satralizumab
Hnub Tim pib siv tau lub khoos kas: Lub Xya Hli Ntuj Tim 22, 2020
Tus kws kho mob
P48-20 CMS Issued Prior Authorization Requirements for Certain Hospital Outpatient Department (OPD) Services – Effective July 1, 2020
Hnub Tim pib siv tau lub khoos kas: Lub Xya Hli Ntuj Tim 01, 2020
Tus kws kho mob
2020 July Bulletins
Hnub Tim pib siv tau lub khoos kas: Lub Xya Hli Ntuj Tim 01, 2020
Tus kws kho mob
QP61-20 Signify Health Virtual Visits for Medicare Advantage and SecureBlue Members
Hnub Tim pib siv tau lub khoos kas: Lub Xya Hli Ntuj Tim 08, 2020
Tus kws kho mob
QP58-20 Commercial Pharmacy Benefit Exclusion for Medical Drugs Anjeso™ , Fetroja™ and Potassium Phosphates
Hnub Tim pib siv tau lub khoos kas: Lub Xya Hli Ntuj Tim 08, 2020